Meena Alnajar is an IPilogue Writer, IP Innovation Clinic Fellow, and a 2L JD Candidate at Osgoode Hall Law School On October 15, 2021, the U.S Patent and Trademarks Office (USPTO) closed the public comment…
Tag: medicine
Insulin Biohackers: Shaking Up a Billion-Dollar Industry
Natalie Bravo is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School. Brief History of Insulin In 1921, Dr. Frederick Banting, Charles Best, and James…
A Win for Patent Law and a Loss for Prostate Cancer
Photo Credits: healthline.com (https://www.healthline.com/health/cancer/cancer-ribbon-colors) Shawn Dhue is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School. Janssen Inc. (“Janssen”), a Canadian pharmaceutical company, sells ZYTIGA under Patent No. 2,661,422 (“422 Patent”).…
in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
1493
What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work
This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…
in Canada, Feature Post, IP, Jurisdiction, Patents, Pharmaceutical Drugs, Uncategorized1by Editor
1344
Trade Secrets, Transparency, and Temporality
Access to information is generally important in a free and democratic society. It’s particularly important in the context of regulating drugs, medical devices, and other products. In Merck Frosst Canada…